Q32 Bio Inc.

NASDAQ: QTTB · Real-Time Price · USD
1.91
0.03 (1.60%)
At close: Aug 15, 2025, 1:21 PM

Q32 Bio Cash Flow Statement

Financials in USD. Fiscal year is undefined.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Net Income
-47.73M -112.96M -42.81M -37.56M
Depreciation & Amortization
487K 578K 370K 47K
Stock-Based Compensation
4.39M 1.43M 1.24M 753K
Other Working Capital
-8.59M -9.3M 28.18M 2.58M
Other Non-Cash Items
-15.22M 21.93M 876K 102K
Deferred Income Tax
n/a n/a 2.42M n/a
Change in Working Capital
-9.64M -7.21M 26.94M 3.68M
Operating Cash Flow
-67.72M -96.23M -10.96M -32.98M
Capital Expenditures
-75K -5K -2.48M -157K
Cash Acquisitions
n/a n/a 130M n/a
Purchase of Investments
n/a -73.24M -157.46M -97.39M
Sales Maturities Of Investments
20M 174.24M 65.46M 49M
Other Investing Acitivies
n/a 554K -37.98M 48.39M
Investing Cash Flow
19.93M 101.33M -2.47M -157K
Debt Repayment
7M n/a 30M n/a
Common Stock Repurchased
n/a n/a n/a n/a
Dividend Paid
n/a n/a n/a n/a
Other Financial Acitivies
46.14M n/a n/a 32.06M
Financial Cash Flow
95.14M 184K 30.07M 20.11M
Net Cash Flow
47.35M 5.28M 16.65M -12.94M
Free Cash Flow
-67.79M -96.46M -13.44M -33.14M